Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT02829658 Completed - Clinical trials for Borderline Personality Disorder

Use of Care Services by Patients With Borderline Personality Disorder

EpiB
Start date: February 2009
Phase: N/A
Study type: Observational

Borderline personality disorder (BPD) is characterized by a pervasive pattern of instability and impulsivity. Several North American prospective studies support the high level of mental health care utilization in this population. There is little data in other systems of health organization, such as France. Furthermore, little is known on the variables associated with the mental health service utilization among BPD patients. The main objective was to compare the utilization of mental health care among BPD patients, to the general population and patients with another personality disorder (PD) and to describe the demographic and clinical factors associated with the group of patients who use the most health care.

NCT ID: NCT02829645 Active, not recruiting - Eating Disorders Clinical Trials

Evaluation of the Clinical, Neuropsychological and Psychosocial Situation of Patient With Eating Disorders.

Start date: February 2012
Phase: N/A
Study type: Interventional

Eating disorders (ED) are serious mental illnesses with an excess mortality and many affects in the quality of life of patients and thier relatives. Management of ED is very difficult : the prognosis remains relatively poor both in terms of remission rate and quality of life. In this context, the contribution of new strategies for pathophysiological exploration and the development of therapeutic options are crucial. In this project the investigators aim to constitute un cohort of patients from a day unit specialized in the management of ED. A prospective follow-up will be offered to patients to assess their clinical and psycho-social evolution. The overall objective is to identify which factors are prognostic of clinical improvement of the ED. We also want to better characterize patients that will migrate from diagnosis to another.

NCT ID: NCT02828813 Completed - Cognition Disorders Clinical Trials

Neural Mechanisms of Motor and Cognitive Networks

Start date: June 2016
Phase:
Study type: Observational

This study investigates the neural mechanisms of motor and cognitive networks using cognitive assessment, reaction time measurement, high-density EEG and fMRI.

NCT ID: NCT02827279 Terminated - Clinical trials for Autism Spectrum Disorder

Study of the Visual Perception During Emotional States on Subjects With an Intrusive Disorder of the Development

VisioTED
Start date: March 4, 2013
Phase: N/A
Study type: Interventional

The Pervasive Developmental Disorders (PDD) are severe neurodevelopmental disorders, affecting nearly 1% of the general population. The disorder of social interaction has often been described as resulting from poor emotion recognition, or a bad perception of biological motion. However, the results of studies on these issues are very divergent. The PDD also been described as a disorder of emotion regulation, but few studies address the emotional feelings of individuals with ASD and their neuropsychological implications. The main objective is to study the effect of induced emotion in the children with ASD on his visual exploration strategies. This is a comparative exploratory pilot study. We'll look at using the eye-tracking, policy terms of the look in a group of children with ASD, in a context of emotional induction (joy, fear, sadness or anger) using of sound stimuli.

NCT ID: NCT02825927 Completed - Quality of Life Clinical Trials

Swallowing Function, Oral Health, and Food Intake in Old Age

SOFIA
Start date: October 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a specific rehabilitation program with oral screen used in an elderly population with dysphagia can improve elderly's swallowing capacity.

NCT ID: NCT02825732 Completed - Clinical trials for Neurocognitive Disorders

MEMORA-Caregiver : Risk Factors of Caregiver Burden Among Patients With Neurocognitive Disorders or Subjective Cognitive Complaint

MEMORA
Start date: November 2011
Phase: N/A
Study type: Observational

The investigators will investigate which patients' characteristics are associated with caregivers burden and its evolution for outpatients visiting a memory clinic, in particular how functional autonomy, behavioral and psychological symptoms as well as patients comorbidities can influence caregiver burden. The study will be conducted among outpatients with progressive cognitive complaint followed in a Memory Clinic and their primary caregiver. The investigators hypothesis that caregivers experience a higher burden due to disease symptoms such as impairment of functional autonomy, behavioral and cognitive impairment, whatever the aetiology of the cognitive decline.

NCT ID: NCT02824341 Completed - Parkinson's Disease Clinical Trials

Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior Disorder

MP-TCSP-IRMf
Start date: October 2015
Phase: N/A
Study type: Interventional

Up to 60% of Parkinson's Disease (PD) patients suffer from REM sleep behavior disorder (RBD), a parasomnia. This disorder is thought to be related to a dysfunction of limbic system and brainstem. Impulse control disorders (ICD) are found in about 14% of PD patients taking dopaminergic drugs. These disorders are thought to be related to a dysfunction of meso-cortico-limbic pathways which belong to the so-called "reward system". A strong link was found between these two disorders and therefore the investigators believe that RBD is associated with impaired reward system. The main objective of this study is to evaluate differences in brain activation between PD patients with and without RBD. The investigators hypothesize that PD patients with RBD have a more severe dysfunction of the reward system (hypoactivation of the meso-cortico-limbic pathway) than patients without RBD, explaining their susceptibility to ICD when exposed to high doses of dopaminergic treatment.

NCT ID: NCT02823158 Terminated - Parkinson Disease Clinical Trials

Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM

LATESTIM
Start date: September 2016
Phase: N/A
Study type: Interventional

Deep brain stimulation (DBS) is an established treatment for advanced complicated Parkinson's disease (PD). Several controlled randomized studies have given proof of an advantage for operated patients as compared to medically treated patients in terms of motor outcome, activities of daily living and health status. However these studies have addressed mostly stimulation of the subthalamic nucleus (STN). GPi stimulation has not been compared to best medical treatment (BMT) in a prospective randomized controlled trial in patients with complicated PD who are not good candidates for STN stimulation. The investigators aim assessing GPi-DBS in patients with PD who have contraindications for STN-DBS.

NCT ID: NCT02822443 Completed - Anxiety Disorder Clinical Trials

Improve: Integrating Emotion Focused Components Into Psychological Therapy

Improve
Start date: April 2015
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to compare the efficacy of two treatment-as-usual (TAU) conditions: TAU with integration of emotion focused components (EFT) and TAU with focus on self-regulation (SR). Especially the long-term efficacy is evaluated with a focus on differential effects. Moreover, the mechanisms of change of both conditions are investigated.

NCT ID: NCT02817438 Completed - Anxiety Disorders Clinical Trials

Research on Anxiety and Depression: Computer-Assisted Therapy

RADCAT
Start date: June 2016
Phase: N/A
Study type: Interventional

This study examines how online self-guided programs can improve mood and anxiety symptoms. These programs use exercises from Cognitive-Behavioral Therapy, which is an evidence-based treatment for depression and anxiety. The purpose of this study is to learn who will do best with the online format. Our aim is to learn for whom online self-guided interventions are most efficacious. This knowledge is important because it will help inform clinicians and patients about who might benefit from this type of intervention versus who would need the assistance of a therapist. More specifically, we hope to figure out who would benefit from solely an online intervention and who would benefit from an online intervention in addition to other treatment.